ONC
BeiGene, Ltd.
356.00$
-0.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 167.7% | 660.7% | 9,162.0% | 114.9% | 357.0% | 16.6% | 22.9% | 14.0% | 20.2% | 15.5% | 15.6% | 12.5% | |
| -67.7% | -560.7% | -9,062.0% | -14.9% | -257.0% | 83.4% | 77.1% | 86.0% | 79.8% | 84.5% | 84.4% | 87.5% | |
| 167.7% | 660.7% | 9,162.0% | 112.8% | 342.6% | 216.6% | 419.2% | 124.1% | 115.9% | 72.3% | 51.3% | 40.2% | |
| 53.2% | 82.9% | 1,878.2% | 26.3% | 98.6% | – | 194.3% | 84.2% | 90.3% | 61.3% | 48.1% | 39.0% | |
| 53.2% | 82.9% | 1,878.2% | 26.4% | 99.0% | 307.5% | 613.8% | 208.3% | 206.2% | 133.7% | 99.3% | 79.1% | |
| -120.9% | -643.7% | -10,940.2% | -41.3% | -356.1% | -224.2% | -536.7% | -122.3% | -126.4% | -49.1% | -14.9% | 8.4% | |
| 27.2% | 13.9% | 35.8% | 1.7% | 7.0% | – | – | – | 3.7% | 0.2% | 0.6% | 1.1% | |
| -142.3% | -647.7% | -11,136.7% | -38.2% | -348.0% | -220.4% | -523.9% | -122.3% | -138.5% | -33.6% | -14.0% | 7.8% | |
| 29.8% | -23.9% | 5.0% | 0.9% | -8.0% | 1.6% | 3.4% | 1.6% | 3.0% | 2.3% | 2.9% | 2.4% | |
| -140.2% | -647.7% | -11,141.8% | -39.1% | -339.9% | -221.5% | -526.1% | -123.9% | -141.5% | -35.9% | -16.9% | 5.4% | |
| -108.9% | -626.1% | -10,761.8% | -39.3% | -350.8% | -219.8% | -526.4% | -118.4% | -133.8% | -30.0% | -9.5% | 11.5% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.